Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity
Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.
Diagnosis & Disease Information
Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable
Multigene panel testing can identify mutations that warrant management changes in patients who lack BRCA1 and 2.
PRO-CTCAE Provides “Missing Patient Voice” in Reporting Cancer Treatment Symptoms
A prescription drug’s label AE section is almost entirely based on clinicians’ impression of patients’ symptoms, not the patients’ own reports.
Across Racial Groups, Endometrial Cancer Incidence on the Rise
The incidence of endometrial cancers is elevated for women across all racial/ethnic groups, while non-Hispanic black women have excess incidence.
RAD51 Mutations Linked With Moderate Ovarian Cancer Risk
Deleterious mutations in RAD51C and RAD51D genes are associated with increased risk of epithelial ovarian cancer (EOC).
Multigene Testing Identifies More Mutations in Breast, Ovarian Cancer
Multigene testing for hereditary breast and/or ovarian cancer (HBOC) identifies more mutations that are likely to change clinical management.
Routine Clinical Genetic Testing Should Include RAD51C, RAD51D, Study Suggests
RAD51C and RAD51D are moderate ovarian cancer susceptibility genes.
About 30 Percent wth Epithelial Ovarian Cancer Survive Long-term
About thirty percent of women with epithelial ovarian cancer survive for more than 10 years, including some with high-risk disease.
Botulinum Toxin A May Improve Painful Cutaneous Leiomyomas
The use of botulinum toxin to treat painful cutaneous leiomyomas was associated with improved quality of life.
Oral Contraceptives May Protect Against Endometrial Cancer
Use of oral contraceptives confers long-term protection against endometrial cancer.
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...